SR

Soumya Ranjan Mohapatra

Active Director Director DIN 09837412
DIN 09837412 First appointment Dec 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Soumya Ranjan Mohapatra

Data last updated:

Soumya Ranjan Mohapatra is a Director at Theranomicx Biosolutions Private Limited (since 2022). The company operates in Non-Profit Organizations.

DIN 09837412
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 26 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Dec 20222022Active

Board colleagues of Soumya Ranjan Mohapatra

NameDINCompanyDesignation
Gulab Chand Arya11441280Theranomicx Biosolutions Private LimitedDirector

Directorship timeline

Open interactive timeline →
Theranomicx Biosolutions Private Limited
Premium access

Shareholding and investment profile for Soumya Ranjan Mohapatra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soumya Ranjan Mohapatra

Soumya Ranjan Mohapatra currently holds 1 directorship: Theranomicx Biosolutions Private Limited (Director, since 26 Dec 2022).

Soumya Ranjan Mohapatra was first appointed on 26 Dec 2022 as Director at Theranomicx Biosolutions Private Limited.

The current boards of Soumya Ranjan Mohapatra's companies include Gulab Chand Arya (Theranomicx Biosolutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available